Projects per year
Personal profile
Biography
Dean, Faculty of Pharmacy and Pharmaceutical Sciences
Bill Charman is Dean, Faculty of Pharmacy and Pharmaceutical Sciences at Monash University; and the Chair of the FIP (International Pharmaceutical Federation) Education initiative (FIPEd). He received his B Pharm from the Victorian College of Pharmacy (now Monash University) in 1981, his PhD in pharmaceutical chemistry from the University of Kansas in 1985, and a DSc (honoris causa) from the University of London in 2011. He was appointed as the eighth Sir John Monash Distinguished Professor in 2011.
The average annual QS World University rankings for the 2012-2017 period (in the pharmacy and pharmacology discipline) rank Monash University as the number one program in the AsiaPacific, and top ten worldwide (in 2017, Monash pharmacy and pharmacology was ranked number 2 worldwide).
In 2015, in partnership with the Schools of Pharmacy at the University of North Carolina at Chapel Hill (USA) and University College London (UK), Monash formed 'PharmAlliance' to collaboratively undertake major initiatives in education, research and professional engagement.
His research has been characterised by a multidisciplinary and collaborative approach to address major issues in drug discovery (especially for neglected diseases such as malaria), drug delivery and the pharmaceutical sciences. He has published more than 350 scientific papers and communications and given over 170 invited national and international presentations. He has received numerous national and international awards, and in 2016, he was one of seven researchers at MIPS recognised by Thomson Reuters as a HiCi researcher in the field of Pharmacology and Toxicology.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2005 2019
John and Nariel Ware Gift for Fellowship in Pharmacy Education & Leadership
31/10/17 → 30/06/19
Project: Research
High Throughput Cell Genomics Centre
Hertzog, P., Charman, W., Hansbro, P., Hartland, E., Mackay-Fisson, F., Pera, M., Polo, J. & Whisstock, J.
Australian Research Council (ARC), The University of Melbourne, The University of Newcastle, Monash University
1/01/14 → 18/07/16
Project: Research
Low cost, needle-free and non-refrigerated treatment for post-partum haemorrhage
McIntosh, M., Bischof, R., Charman, W., Meeusen, E., Morton, D., Parkington, H. & Prankerd, R.
United States Agency for International Development
30/09/11 → 29/03/13
Project: Research
Lymphotropic Prodrugs: A Novel Mechanism for Targeted Drug Delivery
Porter, C., Charman, W. & Stella, V.
Australian Research Council (ARC), Monash University
4/01/11 → 31/12/14
Project: Research
Structure-based design of inhibitors of oxidative protein folding in enterobacteriaceae
Scanlon, M., Charman, W., Simpson, J. & Heras, B.
National Health & Medical Research Council (NHMRC)
1/01/11 → 31/12/13
Project: Research
Research Output 1984 2019
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists
Riddy, D. M., Cook, A. E., Shackleford, D. M., Pierce, T. L., Mocaer, E., Mannoury la Cour, C., Sors, A., Charman, W. N., Summers, R. J., Sexton, P. M., Christopoulos, A. & Langmead, C. J., 1 Jan 2019, In : Neuropharmacology. 144, p. 244-255 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
High throughput, quantitative analysis of human osteoclast differentiation and activity
Diepenhorst, N., Nowell, C., Rueda, P., Henriksen, K., Pierce, T., Cook, A., Pastoureau, P., Sabatini, M., Charman, W., Christopoulos, A., Summers, R., Sexton, P. & Langmead, C., 15 Feb 2017, In : Analytical Biochemistry. 519, p. 51-56 6 p.Research output: Contribution to journal › Article › Research › peer-review
Isoform-specific biased agonism of histamine H3 receptor agonists
Riddy, D. M., Cook, A. E., Diepenhorst, N. A., Bosnyak, S., Brady, R., La Cour, C. M., Mocaer, E., Summers, R. J., Charman, W. N., Sexton, P. M., Christopoulos, A. & Langmead, C. J., 1 Feb 2017, In : Molecular Pharmacology. 91, 2, p. 87-99 13 p.Research output: Contribution to journal › Article › Research › peer-review
Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)
Dong, Y., Wang, X., Kamaraj, S., Bulbule, V. J., Chiu, F. C. K., Chollet, J., Dhanasekaran, M., Hein, C. D., Papastogiannidis, P., Morizzi, J., Shackleford, D. M., Barker, H., Ryan, E., Scheurer, C., Tang, Y., Zhao, Q., Zhou, L., White, K. L., Urwyler, H., Charman, W. N. & 4 others, 13 Apr 2017, In : Journal of Medicinal Chemistry. 60, 7, p. 2654-2668 15 p.Research output: Contribution to journal › Article › Research › peer-review
The role of lecithin degradation on the pH dependent stability of halofantrine encapsulated fat nano-emulsions
Haidar, I., Harding, I. H., Bowater, I. C., Eldridge, D. S. & Charman, W. N., 7 Aug 2017, In : International Journal of Pharmaceutics. 528, 1-2, p. 524-535 12 p.Research output: Contribution to journal › Article › Research › peer-review
Press / Media
A$9.8 million fight against superbugs
Jian Li, William Charman, Jiangning Song, Anthony Purcell, Paul Hertzog, Darren Creek, Roger Nation, Jurgen Bullita & John Boyce
24/04/14
1 media contribution
Press/Media: Public Engagement Activities